Search

Your search keyword '"Zhu Dalong"' showing total 410 results

Search Constraints

Start Over You searched for: Author "Zhu Dalong" Remove constraint Author: "Zhu Dalong" Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
410 results on '"Zhu Dalong"'

Search Results

1. Research on generalized testing technology of DC-40 GHz RF microsystem in BGA package

2. Advanced glycation end product levels were correlated with inflammation and carotid atherosclerosis in type 2 diabetes patients

7. Clinical Characteristics and Risk Factors of Normocalcemic Primary Hyperparathyroidism

8. WCN24-432 FINERENONE IN CHINESE PATIENTS WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE: A FIDELITY ANALYSIS

9. Dorzagliatin in drug-naïve patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial

10. Dorzagliatin add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial

12. Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes: A FIDELITY Subgroup Analysis

20. Clinical investigation of glucokinase activators for the restoration of glucose homeostasis in diabetes.

23. Finerenone in Patients with Chronic Kidney Disease and Type 2 Diabetes: The FIDELIO-DKD Subgroup from China

25. Evaluation of an mHealth-enabled hierarchical diabetes management intervention in primary care in China (ROADMAP): A cluster randomized trial

27. Blood pressure targets for prevention of cognitive decline in patients with diabetes and hypertension: Design of the Blood Pressure Control Target in Diabetes (BPROAD) Cognitive Study.

28. Rationale and design for the Blood Pressure Control Target in Diabetes (BPROAD) study.

31. Weight loss and metabolic benefits of bariatric surgery in China: A multicenter study.

42. The heterogeneity of islet autoantibodies and the progression of islet failure in type 1 diabetic patients

44. 93-LB: A Randomized Clinical Trial of Safety, Pharmacokinetics, and Pharmacodynamics of Weekly Dosing Supagutide in Healthy Chinese Subjects

45. 826-P: Effect of Finerenone on Occurrence of Vision-Threatening Events in Patients with DR

47. Additional file 1 of Increased plasmablasts enhance T cell-mediated beta cell destruction and promote the development of type 1 diabetes

48. Carotid atherosclerosis: An independent risk factor for small fiber nerve dysfunction in patients with type 2 diabetes mellitus.

49. Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study

Catalog

Books, media, physical & digital resources